Wolfe M S, Moede A L
Am J Trop Med Hyg. 1978 Jul;27(4):762-5. doi: 10.4269/ajtmh.1978.27.762.
Two cases of serum sickness from furazolidone (Furoxona), prescribed for giardiasis in Latin America, are described. No previous case of serum sickness related to this drug has been reported in the United States. Tartrazine (yellow dye number 5), a component of furazolidone tablets (Furoxona) manufactured in Latin America countries but no longer included in the drug (Furoxone) in the United States is suggested as a possible cause of serum sickness.
本文描述了在拉丁美洲因使用呋喃唑酮（痢特灵）治疗贾第虫病而导致血清病的两例病例。美国此前尚未有与该药物相关的血清病病例报告。拉丁美洲国家生产的呋喃唑酮片（痢特灵）中的一种成分酒石黄（食用色素黄5号），在美国已不再包含在该药物（Furoxone）中，被认为可能是血清病的病因。
